Contents

Glossary

• 1.7.1 Opererations/Policies of the Committee
  • 1.7.1.4 Appendix E
• 1.8 NDPSC working parties
  • 1.8.1 Trans-Tasman Harmonisation Working Party
    • 1.8.1.2 Antibiotic Substances (Nisin)
    • 1.8.1.3 Strychnos spp
    • 1.8.1.5 Salbutamol and Terbutaline
  • 1.8.2.1 Propantheline
  • 1.8.2.2 Amphotericin
• 1.9 Proposed changes to the SUSDP
• 2. Proposed changes/additions to Parts 1 to 3 and Part 5 of the Standard for the Uniform Scheduling of Drugs and Poisons
  • 2.1 SUSDP, Part 1
  • 2.2 SUSDP, Part 2
    • 2.2.1 Labels and containers
  • 2.3 SUSDP, Part 3

Top of page

Agricultural/Veterinary, Industrial and Domestic Chemicals

3. Matters arising from the minutes of the previous meeting (consideration of post-meeting submissions under 42ZCZ)

• 3.1 Octenol

4. Other outstanding matters from previous meetings

• 4.1 Eyelash and eyebrow tinting products
• 4.2 Methylcyclopentadienyl magnesium tricarbonyl
• 4.3 Creosote
• 4.4 Alkaline salts
• 4.5 Flumiclorac pentyl
• 4.6 Permethrin
• 4.7 Sodium hypochlorite

5. Proposed changes/additions to the Standard for the Uniform Scheduling of Drugs and Poisons

• 5.2 SUSDP, Part 5
  • 5.2.1 Warning statements and general safety directions established by CPAS for agricultural and veterinary chemicals (standing agenda item)

6. Matters referred by the Australian Pesticides and Veterinary Medicines Authority

• 6.1 Iminoctadine trialbesilate
• 6.2 N-cyclohexyldiazeniumdioxy-potassium
• 6.3 Deltamethrin
• 6.4 Pine oils
• 6.5 Pyrithione copper
• 6.6 Pyraflufen ethyl
• 6.7 Cyhalofop butyl
• 6.8 Procymidone
• 6.9 Butorphanol
• 6.10-6.11 Potassium sorbate/sodium propionate

Top of page

7. Matters referred by Office of Chemical Safety (OCS)

• 8.1 Sulfacetamide
• 8.2-8.4 Tetracyclines

9. Other matters for consideration

10. Initial review and/or formal opinions (ag/vet, industrial & domestic chemicals)

11. Information items (ag/vet, industrial & domestic chemicals)

Top of page

Pharmaceuticals

12. Matters arising from the minutes of the previous meeting (consideration of post-meeting submissions under 42ZCZ)

• 12.1 Porcine pancreatic enzymes
• 12.2 Kava and kavalactones

13. Other outstanding matters from previous meetings

• 13.1 Melia azedarach
• 13.2 Pseudoephedrine
• 13.3 Medical devices
• 13.4 Aspirin
• 13.5 Ketamine
• 13.6 Aripiprazole
• 13.8 Rosuvastatin
• 13.9 Diclofenac

Top of page

14. Proposed changes/additions to the Standard for the Uniform Scheduling of Drugs and Poisons

• 14.1 SUSDP, Part 4
  • 14.1.2 Neomycin, Polymyxin & Bacitracin
  • 14.1.3 Oseltamivir
  • 14.1.4 Silicones
• 14.2 SUSDP, Part 5
  • 14.2.1 Appendix H

15. Matters referred by the Australian Drug Evaluation Committee (ADEC)

• 15.1 New substances
  • 15.1.1 Disodium gadoxetate
  • 15.1.2 Fosamprenavir
  • 15.1.3 Lumiracoxib
  • 15.1.4 Carbetocin
  • 15.1.5 Pemetrexed
• 15.2 For information (substances already scheduled)
  • 15.2.1 Ketotifen

16. Other matters for consideration

• 16.2 Hyoscyamus niger and atropine - clarification of Schedule 2 entry
• 16.3-16.4 2,5-Dimethoxy-4-iodophenethylamine and 5-methoxy-α-methtryptamine

17. Matters referred by the Medicines Evaluation Committee (MEC)

• 17.1 Nicotine
• 17.2 Quinine

18. Matters referred by the Medicines Classification Committee (MCC) of New Zealand

• 18.1 Zinc compounds

22. Amendments to the SUSDP

• 22.1 Editorials and errata